Adapalene + Benzoyl Peroxide
Neladap gel belongs to a group of medicines called "topical anti-acne agents". It is used to treat mild to moderate acne vulgaris, with open and closed comedones, multiple papules and pustules (inflammatory lesions).
It contains two active substances, adapalene and benzoyl peroxide, which work together but in different ways.
Neladap should only be used in adults and adolescents aged 12 years and older.
Before starting to use this medicine, discuss it with your doctor or pharmacist.
Do not use this gel on skin with cuts, abrasions or eczema.
Be careful not to get this gel in your eyes, mouth, nose or other sensitive areas of the body.
If this happens, rinse the area with plenty of warm water.
Avoid excessive exposure to sunlight and UV lamps.
Avoid contact of this gel with hair or dyed fabrics, as it may discolor them.
After using the medicine, wash your hands thoroughly.
If you experience persistent skin irritation after starting treatment with the gel, contact your doctor (see section 3. How to use Neladap).
Do not use other anti-acne medicines (containing benzoyl peroxide and/or retinoids) at the same time as the gel.
Do not use this medicine at the same time as cosmetics that irritate, dry or peel the skin.
Other medicines may affect the treatment or the gel, so tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
DO NOT USENeladap during pregnancy or if you are planning to become pregnant.
For more information, consult your doctor.
If you become pregnant while using this medicine, stop treatment and inform your doctor as soon as possible for further monitoring.
Breast-feeding
If you are breast-feeding, consult your doctor before using this medicine. Your doctor will advise you whether to stop breast-feeding or avoid using the gel.
If your doctor recommends continuing treatment, do not apply the gel to the breast area to prevent exposure of the child to the medicine.
Neladap has no or negligible influence on the ability to drive and use machines.
This medicine contains 40 mg of propylene glycol (E1520) per gram of gel, which corresponds to 4% w/w.
This medicine contains 3 mg of polysorbate 80 per gram of gel, which corresponds to 0.3% w/w.
This medicine should always be used as directed by your doctor. If you are unsure, consult your doctor or pharmacist.
This medicine is intended for use only in adults and adolescents aged 12 years and older. This medicine is for use on the skin only.
Your doctor will decide which strength of the gel you need, depending on the severity of the condition and the appearance of the acne lesions. Your doctor will also decide whether to use additional treatment.
Your doctor will tell you how long to use this medicine. If there is no improvement after 4-8 weeks, discuss the benefits of continuing treatment with your doctor.
If you experience persistent skin irritation during the first weeks of using the gel, contact your doctor. Your doctor may recommend using a moisturizing cream, applying the gel less frequently, temporarily stopping treatment or completely stopping treatment with the gel.
Do not use cosmetics (such as other face creams or makeup products) before applying the gel daily. These products can be applied after the gel has been absorbed.
This medicine should not be used in children under 12 years of age.
Using more gel on the skin than recommended will not lead to faster improvement of acne, but may cause irritation and redness of the skin.
Contact your doctor or go to the hospital:
Your doctor will tell you what actions to take.
Do not use a double dose to make up for a forgotten dose.
Lesions (comedones, papules and pustules) will decrease only after several applications of the medicine.
Continue to use this medicine for as long as your doctor recommends.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
About 1 in 10 people using this medicine may experience unwanted skin reactions.
Stop using the medicine and seek immediate medical attention if you experience a feeling of tightness in the throat or swelling of the eyes, face, lips or tongue, weakness or difficulty breathing. Stop using the medicine if you experience hives or itching of the face or body. The frequency of these side effects is not known.
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Besides the side effects listed above, the following side effects have also been reported with the use of a lower-strength gel containing adapalene and benzoyl peroxide (1 mg/g + 25 mg/g):
Uncommon(may affect up to 1 in 100 people):
Frequency not known(cannot be estimated from the available data):
Typical side effects that occur with the use of Neladap are mild to moderate reactions at the application site, such as skin irritation with redness, dryness, peeling, stinging or burning sensation of the skin.
Burning sensations at the application site are usually superficial, but cases of more severe burning sensations with blisters have been reported.
If persistent skin irritation occurs during the first weeks of using the medicine, contact your doctor. Skin side effects, such as skin irritation, occur more frequently with the use of a higher-strength gel than with a lower-strength gel (adapalene and benzoyl peroxide 1 mg/g + 25 mg/g). Your doctor may recommend using a moisturizing cream, applying the gel less frequently, temporarily stopping treatment or completely stopping treatment with the gel.
These side effects usually occur at the beginning of treatment and tend to disappear over time.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
Side effects can also be reported to the marketing authorization holder.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and tube after EXP = Expiry date. The expiry date refers to the last day of that month.
Do not store above 30°C.
After first opening the tube, the medicine should be used within 3 months.
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Homogeneous, non-transparent gel, white to very pale yellow in color.
The gel is packed in white HDPE/LLDPE plastic tubes with a white HDPE neck and a peel-off type aluminum seal, with a white PP cap, in a cardboard box.
Available pack sizes:
1 tube of 15 g, 30 g, 45 g or 60 g.
Not all pack sizes may be marketed.
Glenmark Pharmaceuticals s.r.o.
Hvězdova 1716/2b
140 78 Prague 4
Czech Republic
Adalvo Limited
Malta Life Sciences Park, Building 1, Level 4
Sir Temi Zammit Buildings
SGN 3000 San Gwann
Malta
Beltapharm S.p.A.
Via Stelvio 66
20095 Cusano Milanino
Italy
Glenmark Pharmaceuticals Sp. z o. o.
ul. Dziekońskiego 3
00-728 Warsaw
Email: poland.receptionist@glenmarkpharma.com
Country | Medicine name |
Netherlands | Adapalene/Benzoylperoxide Glenmark 3 mg/g + 25 mg/g Gel |
Germany | Adapalen/Benzoylperoxid Glenmark 3 mg/g + 25 mg/g Gel |
Poland | Neladap |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.